New hope for glioblastoma? drug combo trial launches
Disease control
Ongoing
This phase 2 trial tests the drug azeliragon, taken as a capsule, together with radiation therapy for people with a specific type of glioblastoma (a fast-growing brain cancer). The study includes 30 participants whose tumors lack a certain DNA marker (MGMT unmethylated). The goal…
Phase: PHASE2 • Sponsor: Cantex Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC